%0 Journal Article
%T COVID-19免疫学研究现状分析<br>Analysis of the Current Status of COVID-19 Immunology Studies
%A 王邦惠
%J Journal of Clinical Personalized Medicine
%P 499-505
%@ 2334-3443
%D 2024
%I Hans Publishing
%R 10.12677/jcpm.2024.32073
%X 新型冠状病毒肺炎(COVID-19)是由SARS-CoV-2引起的一种疾病，能够导致人类轻度至重度感染，严重急性呼吸系统综合征冠状病毒2型感染具有广泛的临床表现，从无症状到有症状，包括呼吸道症状、发烧、呼吸急促、咳嗽、呼吸困难和病毒性肺炎，在严重病例中，还包括肺炎、严重急性呼吸系统综合征、心力衰竭、肾衰竭，甚至死亡。然而，与新冠肺炎相关的主要死亡原因是呼吸衰竭，其次是感染性休克、肾衰竭、出血和心力衰竭。为了遏制这一流行病，使用快速技术进行正确诊断起着至关重要的作用。近年来，COVID-19血清学及免疫学变化的研究受到了广泛关注。<br />
COVID-19 is a disease caused by SARS-CoV-2, can cause mild to severe infection in humans, severe acute respiratory syndrome coronavirus 2 infection with a wide range of clinical manifestations, from asymptomatic to symptomatic, including respiratory symptoms, fever, shortness of breath, cough, dyspnea and viral pneumonia, in severe cases, including pneumonia, severe acute respiratory syndrome, heart failure, kidney failure, and even death. However, the leading cause of death associated with COVID-19 was respiratory failure, followed by septic shock, renal failure, bleeding, and heart failure. To contain this epidemic, correct diagnosis using rapid techniques plays a vital role. Recently, the serological and immunological changes of COVID-19 have received much attention.
%K COVID-19，免疫学，血清学<br>COVID-19
%K Immunology
%K Serology
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=89777